Clinical Trials Logo

Filter by:
NCT ID: NCT04579250 Completed - Influenza Clinical Trials

Dose, Safety, Tolerability and Immunogenicity of an Influenza H10 Stabilized Stem Ferritin Vaccine, VRC-FLUNPF0103-00-VP, in Healthy Adults

Start date: October 8, 2020
Phase: Phase 1
Study type: Interventional

Background: The flu is a common viral infection that can be deadly for certain people. Vaccines against flu have been developed to teach the body to prevent or fight the infection. A new vaccine may help the body to make an immune response to H10 flu, a flu strain that infects humans. Objective: To test the safety and effectiveness of the H10 Stabilized Stem Ferritin vaccine (VRC-FLUNPF0103-00-VP or H10ssF-6473). Eligibility: Healthy adults ages 18-70, but not born between 1965-1970 Design: Participants received 1 or 2 vaccinations by injections (shots) in the upper arm muscle over 4 months. Participants received a thermometer and recorded their temperature and symptoms every day on/with/via a diary card for 7 days after each injection. The injection site was checked for redness, swelling, itching or bruising. Participants had 8-10 follow-up visits over 10 months. At follow-up visits, participants had blood drawn and were checked for health changes or problems. Participants who reported influenza-like illness had nose and throat swabs collected for evaluation of viral infection. Some participants had apheresis. A needle was placed into a vein in both arms. Blood was removed through a needle in the vein of one arm. A machine removed the white blood cells and then the rest of the blood was returned to the participant through a needle in the other arm.

NCT ID: NCT04578925 Completed - Breast Feeding Clinical Trials

Happy, Healthy, Loved: A Mobile-delivered Breastfeeding Self-efficacy Intervention for First Time Parents

HHL
Start date: October 1, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to test if a mobile device delivered intervention program can improve breast-feeding self-efficacy in primiparous mothers.

NCT ID: NCT04578912 Completed - Tourette Syndrome Clinical Trials

Transcranial Magnetic Stimulation to Augment Behavior Therapy for Tics

Start date: November 1, 2020
Phase: N/A
Study type: Interventional

The study will examine whether combining Comprehensive Behavioral Intervention for Tics (CBIT) with inhibition of the supplementary motor area (SMA) using transcranial magnetic stimulation (TMS) normalizes activity in the SMA-connected circuits, improves tic suppression ability, and enhances CBIT outcomes in young people with tic disorder. The study will also examine different TMS dosing strategies.

NCT ID: NCT04578886 Completed - Delirium Clinical Trials

The Effect of Guanfacine on Delirium in Critically Ill Patients

Start date: November 23, 2020
Phase: Phase 3
Study type: Interventional

Delirium in patients in the intensive care unit (ICU) is a common problem associated with increased mortality and morbidity, including increased hospital and ICU length of stay, greater hospital cost, increased ventilator days, and long-term cognitive disability. Various pharmacologic agents including dopamine antagonists, acetylcholinesterase inhibitors, melatonin, antipsychotics, alpha-2 agonists, and glutamate antagonists are used for treatment of delirium in the ICU despite the lack of clear evidence of efficacy.Since there is no evidence-based pharmacologic treatment of ICU delirium, current therapy is focused on non-pharmacologic prevention techniques and pharmacologic agents are used once delirium is established. Guanfacine, an alpha-2 agonist, has been identified as a potential medication that may be of benefit in the treatment of delirium. The purpose of this study to investigate the effects of guanfacine versus placebo on delirium in critically ill patients admitted to the ICU and to determine whether guanfacine along with standard of care reduces the duration of delirium, compared to standard of care alone.

NCT ID: NCT04578873 Completed - Clinical trials for Bacterial Infections

Phase 1 Oral QPX7831 SAD and MAD in Healthy Adults

Start date: April 13, 2021
Phase: Phase 1
Study type: Interventional

This Phase 1 study will assess the safety, tolerability, and pharmacokinetics (PK) of QPX7831, a beta-lactamase inhibitor, when administered orally in single ascending doses and in multiple ascending doses to heathy adult subjects.

NCT ID: NCT04578574 Completed - Neuropathic Pain Clinical Trials

Effects of Bodily Illusion and tDCS on SCI-related Neuropathic Pain

Start date: January 13, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effect of a combination of two procedures: (1) Bodily Illusion (BI) and (2) Transcranial direct electrical stimulation (tDCS) on neuropathic pain.

NCT ID: NCT04578535 Completed - Healthy Volunteers Clinical Trials

A Study to Assess the Tolerability, Safety, and Pharmacokinetics of Subcutaneous Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) With Ramp-up and No Ramp-up Dosing in Healthy Adult Participants

Start date: October 27, 2020
Phase: Phase 1
Study type: Interventional

The purpose of the study is to assess the tolerability, safety, and pharmacokinetics of HYQVIA with ramp-up and no ramp-up dosing in healthy adult participants.

NCT ID: NCT04577612 Completed - Anxiety Clinical Trials

A Randomized Controlled Test of the Effects of CHI-554 on Fear.

Start date: September 1, 2020
Phase: Phase 2
Study type: Interventional

This is a randomized, double-blind, placebo-controlled phase 2b clinical trial examining the effects of CHI-554 (CBD) on Fear (F-01)

NCT ID: NCT04577573 Completed - Clinical trials for Spinal Cord Injuries

Cognitive-based Prosthetics to Improve Grasp and Reaching After SCI

Start date: May 17, 2021
Phase: N/A
Study type: Interventional

Rehabilitation of functional movements after spinal cord injury (SCI) requires commitment and engagement to the processes of physical therapy. Outcomes may be improved by techniques that strengthen cognitive connections between users and physical therapy exercises. The investigators will investigate combinations of virtual reality and innovative wearable technology to accelerate rehabilitation of hand grasp and reach. These devices use multi-sensory feedback to enhance the sense of agency, or feelings of control, and better train movements during physical rehabilitation exercises. The investigators will measure the effect of these devices on improving the speed, efficiency, and accuracy of performed movements in Veterans with SCI.

NCT ID: NCT04577417 Completed - Clinical trials for Attention Deficit Hyperactivity Disorder

Stimulant Medication Effects on Auditory Sensitivity in Teens With ADHD

Start date: September 13, 2020
Phase:
Study type: Observational

The aims of this study are to evaluate auditory sensitivity in teenagers with ADHD using acoustic reflex thresholds (ART) and to examine the effects of ADHD stimulant medication on ART.